Sugi Predict

Sugi Predict / Compounds / SCHEMBL4908016

SCHEMBL4908016

SCHEMBL4908016

COC(=O)c1cc(S(=O)(=O)NCCc2ccc(OCc3cc(F)cc(F)c3)cc2)cc(C)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 3/20 0.49
▸ MMP9 P14780 3/20 0.49
▸ MMP14 P50281 3/20 0.49
▸ ADAM17 P78536 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.47
▸ ERBB2 P04626 1/20 0.46
▸ ERBB4 Q15303 1/20 0.46
▸ SGMS1 Q86VZ5 4/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TBXA2R P21731 1/20 0.43
▸ TBXAS1 P24557 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ AKR1C3 P42330 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904027 0.93 ALDH1A1 (0.53) MMP2MMP9MMP14ADAM17ALDH1A1
SCHEMBL4906724 0.91 MMP2 (0.50) MMP2MMP9MMP14ADAM17ALDH1A1
SCHEMBL4906213 0.90 MMP2 (0.53) MMP2MMP9MMP14ADAM17ALDH1A1
SCHEMBL4911868 0.90 MAOA (0.45) ALDH1A1ERBB2ERBB4SGMS1SMN1; SMN2
SCHEMBL4894408 0.87 ERBB2 (0.51) MMP2MMP9MMP14ADAM17ALDH1A1
SCHEMBL4898037 0.86 ALDH1A1 (0.56) ALDH1A1SGMS1SMN1; SMN2TBXA2RTBXAS1
SCHEMBL4906567 0.85 MMP2 (0.52) MMP2MMP9MMP14ADAM17ALDH1A1
SCHEMBL4895653 0.85 AKR1C3 (0.43) ALDH1A1ERBB2ERBB4SGMS1SMN1; SMN2
SCHEMBL4897615 0.85 ALDH1A1 (0.51) MMP2MMP9MMP14ADAM17ALDH1A1
SCHEMBL4900677 0.84 AKR1C3 (0.46) ALDH1A1ERBB2ERBB4SGMS1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 — — US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 — — US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 — — US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 — — US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP2 4348/4885MMP9 4666/4885MMP14 4675/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MMP2 4105/4885MMP9 4632/4885MMP14 4597/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP2 4105/4885MMP9 4632/4885MMP14 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.